Results for tag: "Alkylating Agent"

Alkylating agents are a class of immunosuppressive drugs used to treat autoimmune diseases, organ transplant rejection, and certain types of cancer. These drugs work by inhibiting the growth of cells, including those of the immune system, and by preventing the formation of new blood vessels. Common alkylating agents include cyclophosphamide, chlorambucil, and melphalan. Alkylating agents are used in combination with other immunosuppressive drugs to reduce the risk of organ rejection and to treat autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis. They are also used to treat certain types of cancer, such as lymphoma and leukemia. The alkylating agent market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and GlaxoSmithKline. Other companies include Sanofi, AstraZeneca, and Bayer. Show Less Read more